Glyceroltrioleate/glyceroltrierucate therapy in 16 patients with X-chromosomal adrenoleukodystrophy/adrenomyeloneuropathy: Effect on clinical, biochemical and neurophysiological parameters
- 1 January 1995
- journal article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 154 (1), 64-70
- https://doi.org/10.1007/bf01972976
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A Two-Year Trial of Oleic and Erucic Acids (“Lorenzo's Oil”) as Treatment for AdrenomyeloneuropathyNew England Journal of Medicine, 1993
- FILM REVIEWThe Lancet, 1993
- The Inflammatory Myelinopathy of Adreno-LeukodystrophyJournal of Neuropathology and Experimental Neurology, 1992
- Dietary erucic acid therapy for X‐linked adrenoleukodystrophyNeurology, 1989
- X‐linked adrenoleukodystrophy: Identification of the primary defect at the level of a deficient peroxisomal very long chain fatty acyl‐CoA synthetase using a newly developed method for the isolation of peroxisomes from skin fibroblastsJournal of Inherited Metabolic Disease, 1988
- Adrenoleukodystrophy: Dietary oleic acid lowers hexacosanoate levelsAnnals of Neurology, 1987
- AdrenoleukodystrophyNeurology, 1986
- Myelin Membrane from Adrenoleukodystrophy Brain White Matter—Biochemical PropertiesJournal of Neurochemistry, 1983
- Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids.1982
- AdrenoleukodystrophyNeurology, 1981